DMK Pharmaceuticals Corp
DMKDelisted Mar 21, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000887247
DMK Pharmaceuticals Corp was delisted on Mar 21, 2024; its insiders filed their last Form 4 on Nov 2, 2023; 29 institutions reported holding it in 13F filings for Q4 2023, worth $350.4K in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding DMK Pharmaceuticals Corp changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 51 | 53 | +2 |
| Shares | 16.2M | 15.1M | −1.08M (−6.7%) |
| Value | $17.8M | $14.6M | −$3.15M (−17.7%) |
New holders (7)
Institutions that held DMK Pharmaceuticals Corp at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 204,870 | $199.0K | 0.02% |
| Atom Investors LP | 56,492 | $55.0K | 0.01% |
| Credit Suisse AG | 24,850 | $24.0K | 0.00% |
| Royal Bank of Canada | 20,000 | $19.0K | 0.00% |
| Affinity Capital Advisors, LLC | 13,180 | $13.0K | 0.00% |
| Jane Street Group, LLC | 11,152 | $11.0K | 0.00% |
| Heritage Wealth Management, LLC | 6 | $0 | 0.00% |
Sold out (5)
Institutions that held DMK Pharmaceuticals Corp at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Balyasny Asset Management LLC | 1,622,510 | $1.78M |
| Goldman Sachs Group Inc | 241,991 | $266.0K |
| Hayden Royal, LLC | 40,015 | $44.0K |
| Natixis | 38,600 | $42.0K |
| Bessemer Group Inc | 1,000 | $1.00K |